Immuno-Biological Laboratories Co Ltd
TSE:4570
Immuno-Biological Laboratories Co Ltd
TSE:4570
Price:
503 JPY
1.21%
Market Closed
Updated:
May 18, 2024
P/S
Price to Sales
Price to Sales
5.9
Current
5.5
Median
3.8
Industry
Higher
than median
Higher
than industry value
Price to Sales (P/S) ratio is a valuation multiple that compares a company’s market capitalization to its revenues. It is an indicator of the value that financial markets have placed on each dollar of a company’s sales.
P/S
=5.9
Market Cap
/
4.7B
Revenue
788.1m
All Countries
| Market Cap | P/S | ||||
|---|---|---|---|---|---|
| JP |
|
Immuno-Biological Laboratories Co Ltd
TSE:4570
|
4.7B JPY | 5.9 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
230.2B USD | 5.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
196.5B USD | 4.5 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
45.2B USD | 6.7 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
42.1B USD | 2.8 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
38.2B CHF | 5.7 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
56.1T KRW | 15.2 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
32.4B USD | 8.6 | |
| IE |
|
ICON PLC
NASDAQ:ICLR
|
26B USD | 3.2 | |
| US |
|
West Pharmaceutical Services Inc
NYSE:WST
|
26B USD | 8.9 | |
| US |
|
Waters Corp
NYSE:WAT
|
21.1B USD | 7.3 |
P/S Forward Multiples
Forward P/S multiple is a version of the P/S ratio that uses forecasted revenue for the P/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/S
N/A
2-Years Forward
P/S
N/A
3-Years Forward
P/S
N/A
You don't have any saved screeners yet
